Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Early expression of mature αβ TCR in CD4 ^- CD8 ^- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.

Autor: Laffey KG; Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212., Stiles RJ; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Ludescher MJ; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Davis TR; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Khwaja SS; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Bram RJ; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095.; Department of Pediatrics, Mayo Clinic College of Medicine, Rochester, MN 55095., Wettstein PJ; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095.; Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN 55095., Ramachandran V; Department of Surgery, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212., Parks CA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Reyes EE; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Ferrer A; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55095., Canfield JM; Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212., Johnson CE; Clinical Flow Cytometry Laboratory, University Hospital, University of Missouri-Columbia, Columbia, MO 65212., Hammer RD; Clinical Flow Cytometry Laboratory, University Hospital, University of Missouri-Columbia, Columbia, MO 65212.; Department of Pathology & Anatomical Sciences, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212., Gil D; Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212.; Department of Surgery, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212.; Department of Biomedical, Biological, & Chemical Engineering, College of Engineering, University of Missouri-Columbia, Columbia, MO 65212., Schrum AG; Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212.; Department of Surgery, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212.; Department of Biomedical, Biological, & Chemical Engineering, College of Engineering, University of Missouri-Columbia, Columbia, MO 65212.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jul 05; Vol. 119 (27), pp. e2118529119. Date of Electronic Publication: 2022 Jun 29.

Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer.

Autor: Khwaja SS; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Roy A; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Markovina S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Dewees TA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Hunt S; Section of Colorectal Surgery, Washington University School of Medicine, St. Louis, Missouri., Tan B; Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri., Myerson RJ; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Olsen JR; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Parikh PJ; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: pparikh@radonc.wustl.edu.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2016 Aug 01; Vol. 95 (5), pp. 1429-1438. Date of Electronic Publication: 2016 Mar 25.

Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.

Autor: Wong N; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.; Department of Biomedical Engineering, Washington University, St. Louis, Missouri., Khwaja SS; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Baker CM; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Gay HA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Thorstad WL; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Daly MD; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Lewis JS Jr; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Wang X; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.; Department of Biomedical Engineering, Washington University, St. Louis, Missouri.

Publikováno v: Cancer medicine [Cancer Med] 2016 Jul; Vol. 5 (7), pp. 1619-28. Date of Electronic Publication: 2016 Apr 25.